企業プロフィール
AVROBIO 株価・ニュース・カタリスト
- ティッカー:
- AVRO
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for AVRO.
企業概要
事業概要
AVROBIO was a gene-therapy company focused on rare disease before its restructuring and public-market decline. Its platform centered on lentiviral gene therapy and genetic medicine.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ before restructuring, AVRO sat in gene therapy.
ビジネスモデルの特徴
The company depended on clinical validation, manufacturing, and the ability to create durable value from gene therapy.
バイオ業界での位置付け
AVROBIO belongs to the historical gene-therapy category rather than the current live public-company set.
今後のカタリスト
- AVROBIO is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live gene-therapy milestone. The market is mainly waiting on corporate clarity.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。